Titre : Tumeurs du bassin

Tumeurs du bassin : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs du bassin : Questions médicales les plus fréquentes", "headline": "Tumeurs du bassin : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs du bassin : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-05", "dateModified": "2024-12-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs du bassin" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tumeurs par siège", "url": "https://recherchemedicale.com/mesh/D009371", "about": { "@type": "MedicalCondition", "name": "Tumeurs par siège", "code": { "@type": "MedicalCode", "code": "D009371", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C04.588" } } }, "about": { "@type": "MedicalCondition", "name": "Tumeurs du bassin", "alternateName": "Pelvic Neoplasms", "code": { "@type": "MedicalCode", "code": "D010386", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Naseema Gangat", "url": "https://recherchemedicale.com/author/Naseema%20Gangat", "affiliation": { "@type": "Organization", "name": "Mayo Clinic, Rochester, MN, USA." } }, { "@type": "Person", "name": "Kilian G M Brown", "url": "https://recherchemedicale.com/author/Kilian%20G%20M%20Brown", "affiliation": { "@type": "Organization", "name": "Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia." } }, { "@type": "Person", "name": "Umberto Gianelli", "url": "https://recherchemedicale.com/author/Umberto%20Gianelli", "affiliation": { "@type": "Organization", "name": "University of Milan, Department of Health Sciences and S.C. Anatomia Patologica, ASST Santi Paolo e Carlo, Milan, Italy." } }, { "@type": "Person", "name": "Jürgen Thiele", "url": "https://recherchemedicale.com/author/J%C3%BCrgen%20Thiele", "affiliation": { "@type": "Organization", "name": "Institute of Pathology, University of Cologne, Cologne, Germany." } }, { "@type": "Person", "name": "Attilio Orazi", "url": "https://recherchemedicale.com/author/Attilio%20Orazi", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Clinical algorithm for the management of advanced pelvic tumours involving the aortoiliac axis.", "datePublished": "2023-03-12", "url": "https://recherchemedicale.com/article/36964055", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejso.2023.03.207" } }, { "@type": "ScholarlyArticle", "name": "Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy.", "datePublished": "2022-08-28", "url": "https://recherchemedicale.com/article/36064632", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejso.2022.08.025" } }, { "@type": "ScholarlyArticle", "name": "Trajectories of Quality of Life After Pelvic Exenteration: A Latent Class Growth Analysis.", "datePublished": "2023-12-29", "url": "https://recherchemedicale.com/article/38156798", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DCR.0000000000003080" } }, { "@type": "ScholarlyArticle", "name": "Feasibility of tracked ultrasound registration for pelvic-abdominal tumor navigation: a patient study.", "datePublished": "2023-05-25", "url": "https://recherchemedicale.com/article/37227572", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11548-023-02937-8" } }, { "@type": "ScholarlyArticle", "name": "Study of the efficacy of 3D-printed prosthetic reconstruction after pelvic tumour resection.", "datePublished": "2023-02-27", "url": "https://recherchemedicale.com/article/36847197", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/08853282231161110" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Recherchemedicale.com", "item": "https://recherchemedicale.com" }, { "@type": "ListItem", "position": 2, "name": "Tumeurs", "item": "https://recherchemedicale.com/mesh/D009369" }, { "@type": "ListItem", "position": 3, "name": "Tumeurs par siège", "item": "https://recherchemedicale.com/mesh/D009371" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs du bassin", "item": "https://recherchemedicale.com/mesh/D010386" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs du bassin - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs du bassin", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-02-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs du bassin", "description": "Comment diagnostique-t-on une tumeur du bassin ?\nQuels tests sont utilisés pour évaluer une tumeur pelvienne ?\nLes marqueurs tumoraux sont-ils utiles ?\nQuand faut-il consulter un médecin pour des symptômes pelviens ?\nLes examens d'imagerie sont-ils douloureux ?", "url": "https://recherchemedicale.com/mesh/D010386?page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs du bassin", "description": "Quels sont les symptômes courants des tumeurs pelviennes ?\nLes tumeurs pelviennes causent-elles des problèmes digestifs ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes tumeurs pelviennes provoquent-elles des douleurs pendant les rapports ?\nLes symptômes varient-ils selon le type de tumeur ?", "url": "https://recherchemedicale.com/mesh/D010386?page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs du bassin", "description": "Peut-on prévenir les tumeurs pelviennes ?\nLe tabagisme augmente-t-il le risque de tumeurs pelviennes ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes dépistages réguliers sont-ils importants ?\nL'exercice physique aide-t-il à prévenir les tumeurs ?", "url": "https://recherchemedicale.com/mesh/D010386?page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs du bassin", "description": "Quels traitements sont disponibles pour les tumeurs pelviennes ?\nLa chirurgie est-elle toujours nécessaire ?\nQuels sont les effets secondaires de la chimiothérapie ?\nLa radiothérapie est-elle efficace pour toutes les tumeurs ?\nPeut-on combiner plusieurs traitements ?", "url": "https://recherchemedicale.com/mesh/D010386?page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs du bassin", "description": "Quelles complications peuvent survenir avec les tumeurs pelviennes ?\nLes tumeurs pelviennes peuvent-elles affecter la fertilité ?\nY a-t-il des risques de récidive après traitement ?\nLes douleurs chroniques sont-elles une complication fréquente ?\nLes tumeurs pelviennes peuvent-elles causer des problèmes urinaires ?", "url": "https://recherchemedicale.com/mesh/D010386?page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs du bassin", "description": "Quels sont les principaux facteurs de risque des tumeurs pelviennes ?\nLes infections peuvent-elles augmenter le risque ?\nLe surpoids est-il un facteur de risque ?\nLes antécédents de cancer augmentent-ils le risque ?\nLe manque d'activité physique est-il un risque ?", "url": "https://recherchemedicale.com/mesh/D010386?page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une tumeur du bassin ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (IRM, scanner) et biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer une tumeur pelvienne ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, des échographies et des examens d'imagerie sont utilisés." } }, { "@type": "Question", "name": "Les marqueurs tumoraux sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains marqueurs peuvent aider à évaluer la présence de tumeurs." } }, { "@type": "Question", "name": "Quand faut-il consulter un médecin pour des symptômes pelviens ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Consultez si vous avez des douleurs persistantes ou des changements urinaires." } }, { "@type": "Question", "name": "Les examens d'imagerie sont-ils douloureux ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des examens d'imagerie ne sont pas douloureux, mais peuvent être inconfortables." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs pelviennes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs pelviennes, saignements anormaux et troubles urinaires." } }, { "@type": "Question", "name": "Les tumeurs pelviennes causent-elles des problèmes digestifs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des douleurs abdominales et des troubles digestifs." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans tumeur visible ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains symptômes peuvent être présents sans tumeur détectable." } }, { "@type": "Question", "name": "Les tumeurs pelviennes provoquent-elles des douleurs pendant les rapports ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent causer des douleurs pendant les rapports sexuels." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type et la localisation de la tumeur." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs pelviennes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures de prévention incluent un mode de vie sain et des dépistages réguliers." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque de tumeurs pelviennes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque pour plusieurs types de cancers." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire le risque de développer des tumeurs." } }, { "@type": "Question", "name": "Les dépistages réguliers sont-ils importants ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter les tumeurs à un stade précoce." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir les tumeurs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut réduire le risque de certains cancers." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs pelviennes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, la chirurgie dépend de la taille et du type de tumeur." } }, { "@type": "Question", "name": "Quels sont les effets secondaires de la chimiothérapie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure nausées, fatigue et perte de cheveux." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace pour toutes les tumeurs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Non, son efficacité dépend du type de tumeur et de son stade." } }, { "@type": "Question", "name": "Peut-on combiner plusieurs traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une approche multimodale est souvent utilisée pour optimiser les résultats." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les tumeurs pelviennes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la propagation de la tumeur et des problèmes fonctionnels." } }, { "@type": "Question", "name": "Les tumeurs pelviennes peuvent-elles affecter la fertilité ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent compromettre la fertilité en affectant les organes reproducteurs." } }, { "@type": "Question", "name": "Y a-t-il des risques de récidive après traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de récidive dépend du type de tumeur et du traitement reçu." } }, { "@type": "Question", "name": "Les douleurs chroniques sont-elles une complication fréquente ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs chroniques peuvent persister après le traitement." } }, { "@type": "Question", "name": "Les tumeurs pelviennes peuvent-elles causer des problèmes urinaires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des difficultés urinaires et des infections." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque des tumeurs pelviennes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, les antécédents familiaux et le mode de vie." } }, { "@type": "Question", "name": "Les infections peuvent-elles augmenter le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections, comme le HPV, sont liées à un risque accru." } }, { "@type": "Question", "name": "Le surpoids est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est associée à un risque accru de plusieurs cancers pelviens." } }, { "@type": "Question", "name": "Les antécédents de cancer augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de cancer augmente le risque de tumeurs pelviennes." } }, { "@type": "Question", "name": "Le manque d'activité physique est-il un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut contribuer à un risque accru de cancer." } } ] } ] }

Sources (7631 au total)

Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy.

To examine characteristics and survival of patients who developed secondary ovarian cancer after external beam radiotherapy (EBRT) for a prior nonovarian pelvic malignancy.... This is a population-based retrospective cohort study, querying the Surveillance, Epidemiology, and End Result program from 1975 to 2016. 167,269 women who received EBRT for 7 malignancies (anus, rect... Following EBRT for a pelvic malignancy, 215 (1.3 per 1000) patients developed secondary ovarian cancer. Among those, the most frequent prior malignancy was cervical cancer (45.6%), followed by rectal ... Radiotherapy-related secondary ovarian cancer may be associated with decreased overall survival....

Trajectories of Quality of Life After Pelvic Exenteration: A Latent Class Growth Analysis.

Information on the course of quality of life after surgery for advanced cancers within the pelvis is important to guide patient decision-making; however, the current evidence is limited.... To identify quality-of-life trajectory classes and their predictors after pelvic exenteration.... Prospective cohort study.... Highly specialized quaternary pelvic exenteration referral center.... Patients undergoing pelvic exenteration due to advanced/recurrent cancers within the pelvis between July 2008 and July 2022.... Quality-of-life data included the 36-item Short-Form Survey (physical and mental component scores) and the Functional Assessment of Cancer Therapy-Colorectal instruments, which were collected at 11 di... The study included 565 participants. Two distinct quality-of-life trajectory classes were identified for the Physical Component Score (class 1: high stable and class 2: high decreasing). Three distinc... This study was conducted at a single highly specialized quaternary pelvic exenteration referral center, and findings may not apply to other centers.... This study demonstrates that quality of life after pelvic exenteration diverges into distinct trajectories, with most patients reporting an optimal course. See Video Abstract .... ANTECEDENTES:La información sobre la evolución en la calidad de vida después de cirugía en cánceres avanzados situados en la pelvis es importante para guiar la toma de decisiones sobre el paciente; si...

Feasibility of tracked ultrasound registration for pelvic-abdominal tumor navigation: a patient study.

Surgical navigation techniques can guide surgeons in localizing pelvic-abdominal malignancies. For abdominal navigation, accurate patient registration is crucial and is generally performed using an in... Patients scheduled for surgical navigation during laparotomy of pelvic-abdominal malignancies were prospectively included. In the operating room, two percutaneous tracked US scans of the pelvic bone w... In total, 18 patients were included and analyzed. US registration resulted in a mean surface registration error of 1.2 ± 0.2 mm and a mean target registration error of 3.3 ± 1.4 mm. US acquisitions we... US registration based on the pelvic bone is accurate, fast and feasible for surgical navigation. Further optimization of the bone segmentation algorithm will allow for real-time registration in the cl... This study is registered in ClinicalTrials.gov (NCT05637359)....

Lumbosacral plexopathy caused by the perineural spread of pelvic malignancies: clinical aspects and imaging patterns.

Perineural spread (PNS) of tumors from pelvic malignancies is a rare phenomenon but constitutes an important differential diagnosis of lumbosacral plexopathy (LSP). Herein, we describe the clinical an... We retrospectively reviewed 9 cases of LSP caused by PNS of pelvic malignancy between January 2006 and August 2021, and all clinical and imaging parameters were recorded in detail. Clinical symptoms a... This study enrolled nine adult patients (mean age, 50.1 years). Two cases initially presented as LSP and were later diagnosed with pelvic malignancy. Pain in the perianal or inguinal area preceded pai... Though rare, physicians should always keep in mind the possibility of LSP due to the PNS in patients with pelvic malignancy. Thorough physical examination and history taking could provide clues for di...

Long-term Urological Outcomes in Pelvic Genitourinary Rhabdomyosarcoma: A 48-Year Single-center Experience.

Multimodal therapy has improved survival in genitourinary rhabdomyosarcoma, a rare pediatric cancer. However, little is reported regarding postoperative complications and long-term urinary and sexual ... We reviewed records from 1970-2018 to identify patients with genitourinary rhabdomyosarcoma of the bladder, prostate, pelvis, vagina, and uterus. We assessed modes of therapy, and if surgical, the typ... Fifty-one patients were identified for the post-treatment outcomes cohort. All received chemotherapy, 46 (90.2%) underwent surgery, and 34 (67%) received radiation. Twenty-nine patients (56.9%) receiv... Organ-sparing treatment was more likely to predispose patients to high rates of additional reconstructive surgery due to compromised urological function. In survey results, both men and women reported...

The effect of psychosocial interventions for sexual health in patients with pelvic cancer: a systematic review and meta-analysis.

The aim of this systematic review and meta-analysis was to explore and evaluate the effect of psychosocial interventions in improving sexual health outcomes among post-treatment patients with pelvic c... Inclusion and exclusion criteria were pelvic cancer survivors; psychosocial interventions; studies with a control group and measures of sexual health. Five databases were searched for literature along... Thirteen studies were included, with a total number of 1,541 participants. There was a large heterogeneity regarding the type of psychosocial intervention used with the source found in a leave one out... There is limited research on psychosocial interventions for sexual health in pelvic cancer patients. There are also limitations in the different pelvic cancer diagnoses examined. Commonly, the include...